Aspergillus fumigatus is a fungal species that can cause serious illnesses in immunocompromised individuals. Infections caused by A. fumigatus are difficult to eliminate because the fungus often aggregates into small communities called “biofilms,” which protect the pathogens from antifungal agents and help the fungus evade the immune system. GlycoNet scientists Drs. Lynne Howell and Don Sheppard recently identified a key enzyme in A. fumigatus that could lead to therapeutics to treat these fungal infections.
- Tracking the SARS-CoV-2 virus with genome sequencing
- Hospitals leaned toward strict COVID-19 NICU policies despite low prevalence of infection
- Princeton and Mpala scholars link obesity and disease to dramatic dietary changes
- New national poll: young Americans favor reforms
- Perspective: Understanding COVID-19 vaccine efficacy